AIM ImmunoTech Inc.

AIM

Exchange: NYSE
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0000946644

SEC filings (opens in a new tab)

In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.

Superinvestors holding AIM, Q2 2026

See all superinvestors

No superinvestor reported holding AIM in Q2 2026.